Dynamics of elimination of autologus infected MDM and CD8+ cell infiltration in brains of 1-MT mice versus control mice
Treatment group, by week* . | Macrophages per section . | HIV-1 p24+ macrophages, % . | Iba1 area per section, % . | CD8+ T lymphocytes per section . |
---|---|---|---|---|
Week 2 | ||||
Control | 70.83 ± 35.98 | 32.0 ± 9.0 | 3.95 ± 0.46 | 298.0 ± 91.22 |
1-MT | 68.66 ± 23.36 | 42.0 ± 10.77 | 4.65 ± 0.63 | 597.0 ± 109.76† |
Week 3 | ||||
Control | 44.2 ± 25.97 | 53.0 ± 2.51 | 4.52 ± 0.87 | 193.0 ± 106.65 |
1-MT | 9.0 ± 4.65‡ | 53.0 ± 11.32 | 5.07 ± 0.44 | 256.0 ± 45.6 |
Treatment group, by week* . | Macrophages per section . | HIV-1 p24+ macrophages, % . | Iba1 area per section, % . | CD8+ T lymphocytes per section . |
---|---|---|---|---|
Week 2 | ||||
Control | 70.83 ± 35.98 | 32.0 ± 9.0 | 3.95 ± 0.46 | 298.0 ± 91.22 |
1-MT | 68.66 ± 23.36 | 42.0 ± 10.77 | 4.65 ± 0.63 | 597.0 ± 109.76† |
Week 3 | ||||
Control | 44.2 ± 25.97 | 53.0 ± 2.51 | 4.52 ± 0.87 | 193.0 ± 106.65 |
1-MT | 9.0 ± 4.65‡ | 53.0 ± 11.32 | 5.07 ± 0.44 | 256.0 ± 45.6 |